2. The FDA approved the Cologuard Plus test, a next-generation multitarget stool DNA test approved for patients at an average risk for colorectal cancer. In a trial of 19,000 patients, the test ...

The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.

It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

DNA (deoxyribonucleic acid) is the nucleic acid polymer that forms the genetic code for a cell or virus. Most DNA molecules consist of two polymers (double-stranded) of four nucleotides that each ...

Current price $57.75 52-week high $79.62 ...

Included was a final decision related to CMS pricing for Exact Sciences Corp’s (NASDAQ:EXAS) Cologuard Plus, a second-generation test that received FDA approval in October. William Blair writes ...

After hours: 7:35:44 p.m. EST ...

A draw in the third Test between Australia and India has spiced up the race to the World Test Championship Final. Australia and India continue to play catch-up with South Africa after the ...

After hours: 20 December at 7:51:54 pm GMT-5 ...